Frontlight ResearchEarly access
Trial site
University Hospital Vall d'Hebron
- 5running trials
- 6closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Head and neck cancer2 trials
- Myelodysplastic syndromes2 trials
- Acute lymphoblastic leukaemia1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- COPD1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- and 4 more
- Phase
- Phase 35 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Completed6 trials
- Recruiting5 trials
- Suspended1 trial
- Lead sponsor
- Regeneron Pharmaceuticals2 trials
- Apellis Pharmaceuticals, Inc.1 trial
- Bordeaux Colorectal Institute Academy1 trial
- CellCentric Ltd.1 trial
- Clovis Oncology, Inc.1 trial
- and 6 more
Running trials
Recruiting
Recruiting
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
Recruiting
Recruiting
Recruiting
A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Follicular lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroblastoma1 recruiting
Closed trials
Completed
Completed
Assessing the Utility of Peak Inspiratory Flow as a Predictor for COPD Exacerbations
Completed
Recruiting
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026